Does HLA-DQ8 increase risk for celiac disease by promoting gluten-specific T-cell responses?

Clinical evidence

• Susceptibility and Risk Gradient: HLA-DQ8 (encoded by the DQA1*03:01 and DQB1*03:02 alleles) is established as a major genetic risk factor for celiac disease. While HLA-DQ2.5 carries the highest relative risk, HLA-DQ8 acts as the primary genetic driver in approximately 5% to 15% of celiac disease patients, conferring an intermediate level of risk compared to non-carriers.
• Diagnostic Utility: Clinical testing for HLA-DQ8 exhibits a negative predictive value (NPV) approaching 100%. Because these alleles are necessary but not sufficient for disease development (occurring in approximately 30% of the healthy population), their absence effectively rules out a diagnosis of celiac disease, whereas their presence alone is not diagnostic.

Mechanistic explanations

• Transglutaminase 2 (TG2) Deamidation: The dietary proteins in wheat (gluten), barley (hordein), and rye (secalin) are exceptionally rich in proline and glutamine, making them highly resistant to complete enzymatic digestion. In the lamina propria, the enzyme tissue transglutaminase 2 (TG2) deamidates specific neutral glutamine residues within these surviving gluten fragments, converting them into negatively charged glutamate residues.
• Peptide Presentation and Pocket Dynamics: The HLA-DQ8 heterodimer contains a key polymorphism at position β57, where an alanine replaces the negatively charged aspartate found in non-celiac-associated DQ molecules. This eliminates a salt bridge, creating a positively charged P9 binding pocket. This pocket exhibits a highly selective affinity for the negatively charged glutamate residues generated by TG2 deamidation.
• T-Cell Activation: The stable binding of deamidated gluten peptides (such as the immunodominant α-gliadin 23-mer or γ-gliadin epitopes) to the HLA-DQ8 groove allows for the presentation of these antigens to CD4+ T-helper cells via their T-cell receptors (TCRs). This presentation drives robust CD4+ T-cell activation, clonal expansion, and the secretion of pro-inflammatory Th1 cytokines—primarily interferon-gamma (IFN-γ)—which orchestrates mucosal inflammation, intraepithelial lymphocytosis, and downstream villous atrophy.

Bottom line

• HLA-DQ8 is a critical genetic risk factor that enables celiac disease pathogenesis. It acts by creating a positively charged P9 binding pocket that selectively binds negatively charged, TG2-deamidated gluten peptides, presenting them to CD4+ T-cells to drive the inflammatory cascade that causes intestinal mucosal damage.